Cohero Health, a NYC-based digital health company developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has added strategic investors Samsung NEXT and Omron Healthcare to its oversubscribed Series A round. The company originally announced its $9M Series A in late 2016 but elected to allow forthe investment of additional strategic capital. With the addition of the two new strategic investors/partners, the Series A round
Read More
ResApp Expands Research Collaboration With Mass General for Diagnostic App
ResApp, a Australian-based digital health startup that has developed a smartphone app that can diagnose respiratory diseases based on the sound signatures of the coughs has entered into a two-year expanded research collaboration with Massachusetts General Hospital (MGH). As part of the research collaboration, ResApp and MGH will perform additional analysis of the SMARTCOUGH-C study data, use the SMARTCOUGH-C dataset to investigate the state of respiratory disease clinical practice today and
Read More
Propeller Health Lands FDA 510(k) Clearance to Market Sensor for the Ellipta Inhaler
Propeller Health, a Madison, Wisconsin-based provider of digital solutions for respiratory medicine has received FDA 510(k) clearance to market its digital sensor for use with GSK’s Ellipta® patented, dry powder inhaler. The custom sensor designed exclusively for the Ellipta inhaler was cleared as part of a R&D collaboration between Propeller and GSK announced in late 2015.For the R&D collaboration, the Propeller sensor automatically collected and recorded data on the Ellipta inhaler's
Read More
Propeller Health Lands $21.5M to Modernize Respiratory Disease Management
Propeller Health, a digital solution for respiratory medicine has raised $21.5 million in Series C funding from 3M Ventures, S.R. One, Limited, Hikma Ventures and existing investors Safeguard Scientifics and Social Capital. The round also includes participation from existing investors Safeguard Scientifics and Social Capital. The company plans to utilize the funding to expand Propeller’s FDA-cleared digitally-guided therapy platform. Despite an abundance of effective medications, the burden of
Read More
Propeller Health, Aptar Partner To Develop Connected Metered Dose Inhaler
Digital health company Propeller Health is teaming up with Aptar Pharma (Aptar) to develop the world's first integrated connected metered dose inhaler (cMDI), with an integrated sensor and a novel electronic dose counter. The device is currently available for licensing and is expected to enter clinical studies later this year.
Connected Metered Dose Inhaler Development Details
Pressurized MDIs are the most common type of inhaler device on the market today, with over 600 million units
Read More